Evidence map›Paper›PMID 39660057›Full record

ArticleiScience2024

Three-dimensional characteristics of T cells and vasculature in the development of mouse esophageal cancer.

Shanshan Bi, Yueguang Wu, Ning Ding, Yan Zhou, Huijuan Liu, Yongjia Weng, Qiqin Song, Li Zhang, Matthew Yibo Cheng, Heyang Cui and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shanshan BiCancer Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology Medical Center, Shenzhen 518035, P.R. China.
Yueguang WuCancer Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology Medical Center, Shenzhen 518035, P.R. China.
Ning DingCancer Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology Medical Center, Shenzhen 518035, P.R. China.
Yan ZhouInstitute of Cancer Research, Shenzhen Bay Laboratory, Shenzhen 518132, P.R. China.
Huijuan LiuInstitute of Cancer Research, Shenzhen Bay Laboratory, Shenzhen 518132, P.R. China.
Yongjia WengCancer Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology Medical Center, Shenzhen 518035, P.R. China.
Qiqin SongCancer Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology Medical Center, Shenzhen 518035, P.R. China.
Li ZhangCancer Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology Medical Center, Shenzhen 518035, P.R. China.
Matthew Yibo ChengCancer Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology Medical Center, Shenzhen 518035, P.R. China.
Heyang CuiCancer Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology Medical Center, Shenzhen 518035, P.R. China.
Weimin ZhangCancer Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology Medical Center, Shenzhen 518035, P.R. China.
Yongping CuiCancer Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology Medical Center, Shenzhen 518035, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal squamous cell carcinoma (ESCC) is a common malignancy, characterized by a multistep pathogenic process regulated spatiotemporally within the esophageal epithelial microenvironment, including vessel normalization and immune infiltration. However, empirical evidence elucidating esophageal vascular remodeling and immune infiltration during ESCC tumorigenesis

Indexed as

cancerimmune responseVascular remodeling

Identifiers

PMID39660057
PMCPMC11629339

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.